GT Biopharma, Inc. — Form D

GT Biopharma, Inc. of SAN FRANCISCO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2025-03-07. The offering totals $1.3M, of which $1.3M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (25)

NameRoleLocation
Rajesh ShrotriyaDirectorSan Francisco, CA
Bruce WendelDirectorSan Francisco, CA
Anshuman DubeDirectorLas Vegas, NV
Michael BreenDirectorSAN FRANCISCO, CA
Michael BreenExecutive OfficerSAN FRANCISCO, CA
Alan UrbanExecutive OfficerSAN FRANCISCO, CA
Hilary KramerDirectorSAN FRANCISCO, CA
Charles CasamentoDirectorSAN FRANCISCO, CA
Andrew RitterDirectorSAN FRANCISCO, CA
Steven WeldonDirectorBeverly Hills, CA
Steven WeldonExecutive OfficerBeverly Hills, CA
Anthony CataldoDirectorBeverly Hills, CA
Anthony CataldoExecutive OfficerBeverly Hills, CA
Kathleen J Clarence-SmithDirectorTAMPA, FL
Kathleen J Clarence-SmithExecutive OfficerTAMPA, FL
Anthony J CataldoDirectorTAMPA, FL
Jon B BonfiglioDirectorTAMPA, FL
Raymond B UrbanskiExecutive OfficerTAMPA, FL
Peter B KienerDirectorTAMPA, FL
Geoffrey B DavisDirectorTAMPA, FL
Kathleen Clarence-SmithDirectorWashington, DC
Kathleen Clarence-SmithExecutive OfficerWashington, DC
David SaloffDirectorBeverly Hills, CA
Kenneth EatonDirectorBeverly Hills, CA
Kenneth EatonExecutive OfficerBeverly Hills, CA

Other filings by this issuer (10)

FiledFormOfferingSold
2025-05-28D$20.0M
2025-05-27D$6.0M$6.0M
2020-07-23D/A$5.6M
2020-06-12D$2.4M
2018-08-17D$5.1M$5.1M
2018-02-06D$7.1M$7.1M
2017-09-14D$4.5M$4.5M
2015-07-27D$1.5M$500K
2015-03-16D$3.0M$2.0M
2014-07-31D$1.4M$1.4M

More